Key facts
- This page summarizes Cindy Ferguson's Form 4 filing for ATRION CORP.
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Aug 2024, 14:52.
Cindy Ferguson - 21 Aug 2024 Form 4 Insider Report for ATRION CORP
- Reporting relationship
- Officer / CFO
- Issuer ticker
- N/A
- Reported as of
- 21 Aug 2024
- Net transaction value
- -$54,280
- SEC form
- 4
- Accepted by SEC
- 21 Aug 2024, 14:52:24 UTC
- Prior SEC filing
- 22 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/Cindy Ferguson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Cindy Ferguson filed Form 4 for ATRION CORP on 21 Aug 2024.
Change
- Previous filing in this sequence was filed on 22 May 2024.
- Current net transaction value: -$54,280.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATRI
transaction
common stock
Disposed to Issuer
- Transaction value
- $54,280
- Shares
- -118
- Change %
- -100%
- Price
- $460.00
- Shares after
- 0
- Date
- 21 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATRI
transaction
Derivative
restricted stock units
Disposed to Issuer
- Transaction value
- $0
- Shares
- -2,105
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 21 Aug 2024
- Ownership
- Direct
- Underlying class
- common stock
- Underlying amount
- 2,105
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of May 28, 2024, by and among Nordson Corporation, Alpha Medical Merger Sub, Inc., a wholly owned subsidiary of Nordson, and Atrion Corporation. At the effective time of the Merger, (i) each issued and outstanding share of common stock and (ii) each restricted stock unit, performance-based stock unit and deferred stock unit, were thereupon canceled and converted into the right to receive $460.00 in cash.